In a groundbreaking press release on April 10th, 2025, the FDA announced its decision to phase out animal testing requirements for monoclonal antibodies, followed by other drugs – signaling a clear shift towards the use of more relevant human approaches for preclinical safety and toxicity testing. Associated with their announcement was a 5-year roadmap outlining … Continue reading Why the FDA animal testing phase-out for monoclonal antibodies?